You Position: Home > Journal issue
Clinical Oncology and Cancer Research
2024:
2023:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2022:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2021:
2020:
2019:
2018:
2017:
2016:
2015:
2014:
2013:
2012:
2011:
2010:
2009:
2008:
2007:
2006:
2005:
Clinical Oncology and Cancer Research
1
A four-gene signature-derived risk score for glioblastoma:prospects for prognostic and response predictive analyses
Cancer Biology & Medicine, Volume 16, Issue 3,2019, Pages 595-605, doi:10.20892/j.issn.2095-3941.2018.0277
2
Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients
Cancer Biology & Medicine, Volume 16, Issue 3,2019, Pages 556-564, doi:10.20892/j.issn.2095-3941.2018.0506
3
Maintaining proton homeostasis is an essential role of the Warburg effect in proliferating cells
Cancer Biology & Medicine, Volume 16, Issue 3,2019, Pages 391-395, doi:10.20892/j.issn.2095-3941.2019.0151
4
CSN6 promotes tumorigenesis of gastric cancer by ubiquitin-independent proteasomal degradation of p16INK4a
Cancer Biology & Medicine, Volume 16, Issue 3,2019, Pages 514-529, doi:10.20892/j.issn.2095-3941.2018.0410
5
Targeting EZH1/2 induces cell cycle arrest and inhibits cell proliferation through reactivation of p57CDKN1C and TP53INP1 in mantle cell lymphoma
Cancer Biology & Medicine, Volume 16, Issue 3,2019, Pages 530-541, doi:10.20892/j.issn.2095-3941.2018.0380